QNCX today
$31.73+$2.37 (+8.07%)close Oct 9, 2026Trend
DailyNeutral
4 hourStrong Bullish
1 hourLeaning Bearish
15 minStrong Bearish
5 minStrong Bullish
Key levels
Resistance$35.34
Resistance$32.59
Support$26.65
Support$20.72
Latest news & SEC filings
AnalystRaymond James starts Quince Therapeutics at Outperform, $72 target; firm renamed IRulya Therapeutics
All QNCX news →Nasdaq · Healthcare
IRulya Therapeutics Inc. (QNCX)
What Is the Price Target for QNCX?
SEPT Low Target
$61.20
SEPT Mid Target
$72.00
SEPT High Target
$82.80
Analyst Consensus
$72.00
Is QNCX a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for QNCX.
Start Free Trial →Is QNCX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$72.00
34
Moat Score
NONE
1/9
Piotroski Score
-2.3
Altman Z-Score
What Is Smart Money Doing with QNCX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →QNCX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-28.24%
FCF Growth YoY
-29.9%
Revenue Trend
UNKNOWN
Dark Pool Trades for QNCX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for QNCX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:00:00 | $31.73 | 1,239 | $$39K | MIDPOINT |
| 17:13:37 | $34.00 | 1,568 | $$53K | SELL |
| 15:17:55 | $30.65 | 1,567 | $$48K | SELL |
| 15:17:47 | $30.65 | 1,733 | $$53K | MIDPOINT |
| 13:37:04 | $30.35 | 1,000 | $$30K | BUY |
5 dark pool trades shown · $$224K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for IRulya Therapeutics Inc. (QNCX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →QNCX — frequently asked questions
What is QNCX stock price today?
IRulya Therapeutics Inc. (QNCX) is at $31.73, up 8.07% (+$2.37) at the Oct 9, 2026 close.
Why is QNCX stock moving today?
Latest QNCX news — Oct 9, 2026: Raymond James starts Quince Therapeutics at Outperform, $72 target; firm renamed IRulya Therapeutics
What is the QNCX price target?
The average analyst price target for QNCX is $72.00, ranging from $4 to $82, based on 7 analysts. Latest: Quince Therapeutics upgrade on Oct 9, 2026.
What do analysts rate QNCX?
Analyst ratings for QNCX: 1 Buy, 5 Hold, 0 Sell — consensus Hold.
Did QNCX beat earnings?
QNCX last reported on Aug 14, 2026: EPS -$12.31 vs -$28.02 expected — a beat of 56.1%.
Does QNCX pay a dividend?
QNCX does not currently pay a dividend.
What are QNCX support and resistance levels?
Support: $26.65, $20.72, $17.36. Resistance: $32.59, $35.34, $5498.00.
What are insiders doing with QNCX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on QNCX?
Oct 9, 2026: Raymond James starts Quince Therapeutics at Outperform, $72 target; firm renamed IRulya Therapeutics